Get notified when MEHA files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Going Concern (new) — Auditor expressed substantial doubt about ability to continue as going concern due to recurring losses and negative cash flows.
- Material Weakness (new) — Seven material weaknesses identified including management override of controls, insufficient accounting expertise, revenue documentation gaps, preferred stock accounting errors, inventory allowance failures, contract compliance breakdowns, and expense accrual errors.
- Delisting (new) — Received Nasdaq deficiency notice Dec 30, 2025 for failing to maintain $1.00 minimum bid price; must regain compliance by June 29, 2026 or face delisting.
Nutraceutical firm lists on Nasdaq, raises $8M, then faces delisting notice within 60 days
Filed March 27, 2026 · Period ending December 31, 2025 · ~2 min read
Key Changes
-
high
Company completed Nasdaq listing Nov 5, 2025 under ticker MEHA; received deficiency notice Dec 30 for failing to maintain $1.00 minimum bid price for 30 consecutive days. Must regain compliance by June 29, 2026 or face delisting.
Business: Nasdaq listing verify on EDGAR → -
high
Auditor expressed substantial doubt about ability to continue as going concern due to recurring losses, negative cash flows, and accumulated deficit. Seven material weaknesses identified in internal controls including management override of journal entries, insufficient accounting expertise, and revenue documentation gaps.
Controls & Risk Factors verify on EDGAR → -
high
Raised $8M gross proceeds through Series A/B preferred stock in Nov 2025, later restructured in March 2026 into Series C preferred, cash, and 12% secured notes backed by substantially all company assets. Series A valued at 80% discount in exchange, Series C converts at fixed prices $0.30-$0.41.
Business: Preferred stock financing verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (PXED 10-Q) is open in full — no account needed.
Partner
Trade MEHA commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 3, 2026 · How we verify